These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23772499)

  • 1. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 5. Rheumatic diseases--diagnosis and treatments].
    Mimura T
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):862-8. PubMed ID: 23772499
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 10. Obesity-related disorders].
    Ishigaki Y; Katagiri H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):895-901. PubMed ID: 23772504
    [No Abstract]   [Full Text] [Related]  

  • 3. [Not Available].
    Krüger K
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1773-1774. PubMed ID: 29145683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 6. Diabetes and cancer].
    Noto H; Goto A; Tsujimoto T; Noda M
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):869-74. PubMed ID: 23772500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment: 9. Dyslipidemia].
    Arai H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):890-4. PubMed ID: 23772503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Not Available].
    Korsten P; Müller GA
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1775-1777. PubMed ID: 29145684
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diabetes mellitus related common medical disorders : recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment: 3. Primary aldosteronism, resistant hypertension and diabetes mellitus].
    Shibata H; Itoh H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):850-5. PubMed ID: 23772497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 11. Atherosclerosis].
    Watada H
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):902-6. PubMed ID: 23772505
    [No Abstract]   [Full Text] [Related]  

  • 9. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy].
    Bolz M
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of rheumatic diseases in children: special considerations.
    Milojevic DS; Ilowite NT
    Rheum Dis Clin North Am; 2002 Aug; 28(3):461-82. PubMed ID: 12380365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classifying and treating rheumatoid pain. 5 questions point to the diagnosis].
    Märker-Hermann E; Bauer H
    MMW Fortschr Med; 2003 Jul; 145(29-30):47-50. PubMed ID: 12958779
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent advances in Pediatric Rheumatology: July 2015-June 2016.
    Sharma A; Vignesh P; Jindal AK; Gupta A
    Int J Rheum Dis; 2017 Apr; 20(4):504-509. PubMed ID: 28205425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 3. Opportunistic infections].
    Sumida K; Ubara Y
    Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2631-8. PubMed ID: 24400544
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
    Pincus T; Braun J; Kavanaugh A; Smolen JS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatic disease and COVID-19: epidemiology and outcomes.
    Hyrich KL; Machado PM
    Nat Rev Rheumatol; 2021 Feb; 17(2):71-72. PubMed ID: 33339986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of methotrexate.
    Chan ES; Cronstein BN
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S5-8. PubMed ID: 24219035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in Rheumatic Diseases: A Research Agenda.
    Yazdany J
    Arthritis Rheumatol; 2020 Oct; 72(10):1596-1599. PubMed ID: 32705748
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of enthesitis in psoriatic arthritis.
    Kumar N; Kay LJ; Walker DJ
    J Rheumatol; 2004 Nov; 31(11):2311-2; author reply 2312-3. PubMed ID: 15536671
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics and evolution of 38 patients with rheumatic diseases and COVID-19 under DMARD therapy.
    Galarza-Delgado DÁ; Serna-Peña G; Compeán-Villegas JE; Cardenas-de la Garza JA; Pineda-Sic RA; Colunga-Pedraza IJ; Vega-Morales D; Pérez-Barbosa L; Skinner-Taylor CM; Flores-Alvarado DE
    Clin Rheumatol; 2021 Mar; 40(3):1197-1199. PubMed ID: 33231774
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.